Chitra Karki
Senior Director, Liver/Inflammatory Diseases, Global Evidence and Outcomes Takeda Pharmaceutical
Seminars
Thursday 2nd April 2026
Roundtable Discussion: Advancing Patient Outcomes by Addressing Heterogeneity in Crohn’s Disease & Ulcerative Colitis
10:00 am
- Clinical complexity of Crohn’s Disease including fibrostenosis, fistula formation, and inflammation independent complications
- Limitations of current therapies that control inflammation but fail to resolve fibrosis or tissue damage
- Exploring unmet needs and future therapeutics from a clinicians perspective
